DJIA 17,619.61 -156.51 -0.88%
NASDAQ 4,856.31 -44.57 -0.91%
S&P 500 2,053.96 -13.93 -0.67%
market minute promo

Pfizer (NYSE: PFE)

34.39 -0.40 (-1.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $34.39 -1.15%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.84
Previous Close $34.79
Daily Range $34.34 - $34.84
52-Week Range $27.51 - $35.45
Market Cap $210.8B
P/E Ratio 24.67
Dividend (Yield) $1.12 (3.2%)
Ex-Dividend Date
Dividend Pay Date
02/04/15
03/03/15
Volume 5,336,775
Average Daily Volume 28,444,404
Current FY EPS $2.08

Sector

Healthcare

Industry

Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Why It's Not Too Late to Buy Agenus, Inc. Stock

Small-cap biotech Agenus has seen its share price roar higher since acquiring some highly prized assets in immuno-oncology. Here's why this stock could push even higher going forward.

Is It Time To Book Profits? - Cramer's Mad Money (3/31/15)

Merck’s Keytruda Is Ahead, But Bristol-Myers’ Squibb’s Opdivo Could Catch Up

Hospira Presents Data on Retacrit, an Epogen Biosimilar - Analyst Blog

3 Stocks Improving Performance Of The Drugs Industry

XLV, DXGE: Big ETF Inflows

Out of 12 Big Pharma Stocks, This is the 1 You Can Confidently Hold for the Next 10 Years

Big Pharma stocks often have deep product pipelines, substantial cash flow, and healthy dividends, but they are far from created equal. With patent expirations taking their toll, this would appear to be the one Big Pharma stock you can trust over the next decade.

3 Little-Known Biotechs Working On Potential Blockbusters

These three biotechs have promising drugs in their pipelines that address billion dollar drug markets.

Could These Experimental Drugs Eclipse Harvoni's Historic Launch?

Harvoni set the standard for blockbuster drug launches -- but these three drugs just might have a shot at being even bigger.

US IPO Weekly Recap: SolarEdge shines while other IPOs fall flat

See More PFE News...

PFE's Top Competitors

PFE $34.39 (-1.15%)
Current stock: PFE
JNJ $99.07 (-1.52%)
Current stock: JNJ
ROG $82.65 (0.54%)
Current stock: ROG
GSK $46.48 (0.72%)
Current stock: GSK